The Effect of Phytocannabinoids and Endocannabinoids on Nrf2 Activity in the Central Nervous System and Periphery

Author:

Marini Pietro1,Maccarrone Mauro23ORCID,Saso Luciano4ORCID,Tucci Paolo5ORCID

Affiliation:

1. Institute of Education in Healthcare and Medical Sciences, Foresterhill Campus, University of Aberdeen, Aberdeen AB25 2ZD, UK

2. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Via Vetoio snc, Coppito, 67100 L’Aquila, Italy

3. European Center for Brain Research (CERC), Santa Lucia Foundation IRCCS, Via del Fosso di Fiorano 64, 00143 Rome, Italy

4. Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, 00185 Rome, Italy

5. Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy

Abstract

The relationship between nuclear factor erythroid 2-related factor 2 (Nrf2) and phytocannabinoids/endocannabinoids (pCBs/eCBs) has been investigated in a variety of models of peripheral illnesses, with little clarification on their interaction within the central nervous system (CNS). In this context, evidence suggests that the Nrf2-pCBs/eCBS interaction is relevant in modulating peroxidation processes and the antioxidant system. Nrf2, one of the regulators of cellular redox homeostasis, appears to have a protective role toward damaging insults to neurons and glia by enhancing those genes involved in the regulation of homeostatic processes. Specifically in microglia and macroglia cells, Nrf2 can be activated, and its signaling pathway modulated, by both pCBs and eCBs. However, the precise effects of pCBs and eCBs on the Nrf2 signaling pathway are not completely elucidated yet, making their potential clinical employment still not fully understood.

Funder

European Union—Next Generation EU

Publisher

MDPI AG

Reference90 articles.

1. (2024, April 10). UN Commission Reclassifies Cannabis, yet Still Considered Harmful | UN News. Available online: https://news.un.org/en/story/2020/12/1079132.

2. (ScienceInsider, 2024). U.S. Moves to Reclassify Cannabis as a Lower Risk Drug 2024, ScienceInsider.

3. Procaccia, S., Lewitus, G.M., Lipson Feder, C., Shapira, A., Berman, P., and Meiri, D. (2022). Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug. Front. Pharmacol., 13.

4. Phytochemistry of Cannabis sativa L.;ElSohly;Prog. Chem. Org. Nat. Prod.,2017

5. Cannabis: A Treasure Trove or Pandora’s Box?;Solymosi;Mini Rev. Med. Chem.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3